Damage of the cardiovascular system in lysosomal storage disease - mucopolysaccharidosis

Sergiy Mykolayovych Pyvovar1, Iuriy Stepanovych Rudyk1, Tetiana Valentynivna Lozyk1

  • 1Government Institution "L.T. Malaya Therapy National Institute of the National Academy of Medical Sciences of Ukraine", Kharkiv, Ukraine.

Insights

Mucopolysaccharidosis (MPS) frequently causes severe cardiovascular damage, including valve thickening and myocardial hypertrophy, often leading to fatal outcomes. Early detection and treatment are crucial for managing MPS-related heart conditions.

Area of Science:

  • Biomedical Science
  • Genetics
  • Cardiology

Background:

  • Mucopolysaccharidoses (MPS) are a group of rare genetic disorders.
  • Cardiovascular system involvement is a significant and often fatal complication of MPS.
  • Specific MPS types, including Hurler, Hunter, and Maroteaux-Lamy syndromes, exhibit pronounced cardiac pathology.

Purpose of the Study:

  • To review and synthesize existing literature on cardiovascular pathologies in mucopolysaccharidosis.
  • To highlight the common manifestations and challenges in diagnosing cardiac issues in MPS patients.
  • To outline current and emerging therapeutic strategies for cardiovascular complications in MPS.

Main Methods:

  • Literature review and analysis of published data on mucopolysaccharidosis and cardiovascular disease.
  • Synthesis of findings regarding the types and severity of cardiac damage across different MPS subtypes.
  • Examination of diagnostic challenges and treatment modalities.

Main Results:

  • Cardiovascular damage is a hallmark of MPS, affecting all types, with severe implications in Hurler, Hunter, and Maroteaux-Lamy syndromes.
  • Common findings include valvular thickening and dysfunction, myocardial hypertrophy, conduction abnormalities, coronary artery disease, and hypertension.
  • Clinical and functional cardiovascular assessment is complicated by patient physical and intellectual limitations.

Conclusions:

  • Cardiovascular pathology is a critical determinant of morbidity and mortality in mucopolysaccharidosis.
  • Comprehensive management requires addressing diagnostic difficulties and employing advanced therapies.
  • Enzyme replacement therapy and stem cell transplantation show promise for treating cardiovascular complications in MPS.

Related Concept Videos

Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.0K
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
80
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
87
Lysosomes01:31

Lysosomes

Lysosomes are membrane-enclosed spherical sacs derived from the Golgi apparatus. The most important function of the lysosome is degrading macromolecules and biological polymers that are released during membrane trafficking events such as the secretory, endocytic, autophagic, and phagocytic pathways. The degradation is carried out by several hydrolytic enzymes active in an acidic environment of the lysosomal lumen. These acid hydrolases are involved in cellular processes such as cell signaling,...
20.7K
Proteoglycans01:05

Proteoglycans

Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
4.1K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
76